Explore /
Poster
/ A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.

A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.

Authors

Tatsuya Yamashita

Kanazawa University Hospital, Kanazawa, Japan

Tatsuya Yamashita , Yoshikuni Kawaguchi , Shuichi Kaneko , Tadatoshi Takayama , Namiki Izumi , Naoki Yamanaka , Masatoshi Kudo , Mitsuo Shimada , Masafumi Inomata , Hideo Baba , Kazuhiko Koike , Masao Omata , Masatoshi Makuuchi , Yutaka Matsuyama , Norihiro Kokudo , Kiyoshi Hasegawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

UMIN000001796

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4095)

DOI

10.1200/JCO.2022.40.16_suppl.4095

Abstract #

4095

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2021 ASCO Annual Meeting

A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival.

First Author: Masatoshi Kudo

Poster

2017 Gastrointestinal Cancers Symposium

A randomized controlled trial to compare the effectiveness between surgery and radiofrequency ablation for hepatocellular carcinoma: SURF trial.

First Author: Kiyoshi Hasegawa

Poster

2020 ASCO Virtual Scientific Program